1. Academic Validation
  2. M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor

M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor

  • iScience. 2025 Sep 5;28(10):113517. doi: 10.1016/j.isci.2025.113517.
Kun Zhou 1 Xintian Zhang 1 Yu Liang 1 Han Yao 1 Yichao Hou 1 Xingming Zhang 2 Leilei Du 2 Wenfeng Wang 2 Jianhua Wang 2 Xiangjun Meng 1
Affiliations

Affiliations

  • 1 Shanghai Key Laboratory of Gut Microecology and Associated Major Diseases Research, Digestive Disease Research and Clinical Translation Center, Department of Gastroenterology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • 2 Cancer Institute, Shanghai Urological Cancer Institute, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China.
Abstract

Although tumor-associated macrophages (TAMs) play a critical immunomodulatory role in colorectal Cancer (CRC), the mechanisms underlying their polarization remain unclear. This study identifies the P2X4 Receptor (P2X4R) as a crucial mediator of M1-like polarization. During TAM induction in a controlled in vitro system using CRC cell-conditioned medium, we observed P2X4R-mediated calcium influx and subsequent mitochondrial dysfunction through immunofluorescence and mitochondrial assays. This dysfunction led to mitochondrial DNA release and subsequent activation of the cGAS-STING-IFNB1 pathway, driving M1-like polarization of TAMs. Flow cytometry demonstrated that P2X4R-expressing TAMs not only enhanced CD8+ T cell survival and cytotoxicity in vitro but also augmented T cell responses in a syngeneic CRC mouse model. Clinically, reduced P2X4 expression in CRC tissues correlated with poorer prognosis. In conclusion, these findings identify the P2X4R as a key regulator of M1-like TAM polarization, representing a promising target to reprogram TAMs and suppress CRC progression.

Keywords

Cancer; Cell biology; Immunology; Microenvironment.

Figures
Products
Inhibitors & Agonists
Other Products